By Debdeep Gupta | 18 Apr, 2024
Jubilant Pharmova zooms to 52-week high after US FDA classifies Roorkee facility as VAI
Shares of Jubilant Pharmova touched a 52-week high of 699.15 in early trade on April 18 after the company's arm received a 'voluntary action indicated' (VAI) status from the US Food and Drug Administration (US FDA).At 9:21 am, Jubilant Pharmova was quoting Rs 682.00, up Rs 10.40, or 1.55 percent, on the BSE.Jubilant Pharmova Limited’s wholly owned subsidiary Jubilant Pharma Limited, announced th...
Live Comments